Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 18:9:641841.
doi: 10.3389/fped.2021.641841. eCollection 2021.

Case Report: De novo Variants of KMT2E Cause O'Donnell-Luria-Rodan Syndrome: Additional Cases and Literature Review

Yang Li  1   2 , Lijuan Fan  1 , Rong Luo  1 , Zuozhen Yang  3 , Meng Yuan  1   2 , Jinxiu Zhang  1   2 , Jing Gan  1   2
Affiliations
Case Reports

Case Report: De novo Variants of KMT2E Cause O'Donnell-Luria-Rodan Syndrome: Additional Cases and Literature Review

Yang Li et al. Front Pediatr. .

Abstract

Introduction: O'Donnell-Luria-Rodan syndrome was recently identified as an autosomal dominant systemic disorder caused by variants in KMT2E. It is characterized by global developmental delay, some patients also exhibit autism, seizures, hypotonia, and/or feeding difficulties. Methods: Whole-exome sequencing of family trios were performed for two independent children with unexplained recurrent seizures and developmental delay. Both cases were identified as having de novo variants in KMT2E. We also collected and summarized the clinical data and diagnosed them with O'Donnell-Luria-Rodan syndrome. Structural-prediction programs were used to draw the variants' locations. Results: A 186 G>A synonymous variant [NM_182931.3:exon4: c.186G>A (p.Ala62=)] was found in one family, resulting in alternative splicing acid. A 5417 C>T transition variant [NM_182931.3:exon27: c.5417C>T (p.Pro1806Leu)] was found in another family, resulting in 1806 Pro-to-Leu substitution. Both variants were classified as likely pathogenic according to the ACMG (American College of Medical Genetics and Genomics) guidelines and verified by Sanger sequencing. Conclusion: To date, three studies of O'Donnell-Luria-Rodan syndrome have been reported with heterogeneous clinical manifestations. As a newly recognized inherited systemic disorder, O'Donnell-Luria-Rodan syndrome needs to be paid more attention, especially in gene testing.

Keywords: KMT2E; O'Donnell-Luria-Rodan syndrome; epilepsy; neurodevelopmental disorder; whole-exome sequencing.

PubMed Disclaimer

Conflict of interest statement

ZY was employed by Cipher Gene LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Whole-exome sequencing (WES) and Sanger sequencing revealed heterozygous variants in case 1 (p.P1806L) and case 2 (p.A62=). wt, wildtype; mut, mutation.
Figure 2
Figure 2
Functional domains of KMT2E and evolutionary conservation analysis of amino acid residue. (A) Functional domains and regions in KMT2E gene as indicated. Red dots: new mutations in our study; Blue dots: reported mutations; Above bar: Missense mutation; below bar: splicing mutation. (B) Evolutionary conservation of amino acid residue at position 62 and 1806 in the KMT2E gene among species.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Yun H, Damm F, Yap D, Schwarzer A, Chaturvedi A, Jyotsana N, et al. . Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia. Haematologica. (2014) 99:1456–64. 10.3324/haematol.2013.101386 - DOI - PMC - PubMed
    1. Zhang X, Novera W, Zhang Y, Deng LW. MLL5 (KMT2E): structure, function, clinical relevance. Cell Mol Life Sci. (2017) 74:2333–44. 10.1007/s00018-017-2470-8 - DOI - PMC - PubMed
    1. Park K, Kim JA, Kim J. Transcriptional regulation by the KMT2 histone H3K4 methyltransferases. Biochim Biophys Acta Gene Regul Mech. (2020) 1863:194545. 10.1016/j.bbagrm.2020.194545 - DOI - PubMed
    1. Ali M, Rincon-Arano H, Zhao W, Rothbart SB, Tong Q, Parkhurst SM, et al. . Molecular basis for chromatin binding and regulation of MLL5. Proc Natl Acad Sci USA. (2013) 110:11296–301. 10.1073/pnas.1310156110 - DOI - PMC - PubMed
    1. Deng L-W, Chiu I, Strominger JL. MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proc Natl Acad Sci USA. (2004) 101:757–62. 10.1073/pnas.2036345100 - DOI - PMC - PubMed

Publication types